| Generic Drug/Consistency Evaluation Platform |
蟹爪兰
菊芋
榆树
郁金香
吊灯扶桑
Services and Solutions
Fukangren is committed to the research and development of new drugs and the consistency evaluation of generic drugs. It has a strong team of highly educated core personnel with rich experience in new drug R&D and industrialization.
CDMO
Focus on the development of high-end preparations and international cooperation in...
About Us
Beijing Fukangren Biopharmaceutical Technology Co., Ltd. started its drug R&D service in 1999 and is the CRO company with the longest continuous service time in China. Owns 3 pharmaceutical R&D centers, 1 clinical R&D center, 4 API production bases and 1 preparation production base
Contact Us
Sound organization, high-quality quality management team, complete document management system...
Sustained and controlled release preparations
High-end preparation platform
Committed to research and development of new drugs and consistency evaluation of generic drugs
Technical advantages
Core technologies
Multiple core technologies such as membrane-controlled sustained-release tablets, double-layer controlled-release tablets, sustained-release pellets, osmotic pump controlled-release tablets, etc.
Establish dissolution model database of various sustained-release preparations
Effectively guarantee the durability of the prescription process and the high consistency of dissolution
Rich experience in industrialization
Effectively solve or circumvent the problems encountered in the industrialization of sustained-release preparations
Series products
Equipment advantages
The platform has suchMultifunctional fluidized bed, laser drilling machine, dry granulator, fully automatic high-efficiency coating machine Such as domestic first-class preparation equipment, advanced and complete analysis equipment..
